Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer (original) (raw)

Investigational New Drugs, 2012

Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignancies

Yuichi Takiguchi

International Journal of Oncology, 2015

View PDFchevron_right

The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor

Christine Bolitho

Endocrine-related Cancer, 2010

View PDFchevron_right

Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas

Allen Choi

Journal of Oncology, 2019

View PDFchevron_right

CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers

Sumeet Singh

The American Journal of Pathology, 2020

View PDFchevron_right

Expressions of CXCR7/ligands may be involved in oral carcinogenesis

Yun Hong

Journal of Molecular Histology - J MOL HISTOL, 2011

View PDFchevron_right

BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells

Yasumasa Kato

Biochemical and Biophysical Research Communications, 2006

View PDFchevron_right

Significance of the TGF-β1/IL-6 axis in oral cancer

Wen-hung Wang

Clinical Science, 2012

View PDFchevron_right

Presence of Membrane-Bound TGF- 1 and Its Regulation by IL-2-Activated Immune Cell-Derived IFN- in Head and Neck Squamous Cell Carcinoma Cell Lines

Y-o. Ahn

The Journal of Immunology, 2009

View PDFchevron_right

Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent

Sheng-tsung Chang, Trond Halstensen

European Journal of Oral Sciences, 2009

View PDFchevron_right

Cyclic AMP-Responsive Element Binding Protein– and Nuclear Factor-κB–Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis

Hoa Tran

Cancer Prevention Research, 2008

View PDFchevron_right

Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions

Yun Hong

Mediators of Inflammation, 2012

View PDFchevron_right

Functional expression of the chemokine receptor XCR1 on oral epithelial cells

Paula Farthing

The Journal of Pathology, 2010

View PDFchevron_right

Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblasts

Ilona Kovalszky

Experimental Cell Research, 2011

View PDFchevron_right

Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis

Branko Dmitrović

Head & Neck Oncology, 2010

View PDFchevron_right

Functional Role of the Chemokine Receptor XCR1 and its Bioengineered Ligand in Oral Squamous Cell Carcinoma (OSCC)

Amir Zaki

2018

View PDFchevron_right

Interleukin-1-mediated effects of normal oral keratinocytes and head and neck squamous carcinoma cells on extracellular matrix related gene expression in fibroblasts

Malin Hakelius

Oral Oncology, 2012

View PDFchevron_right

Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism

Elena Loukinova

Oncogene, 2000

View PDFchevron_right

IL-1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer

Chiung-tong Chen

Journal of Cellular Physiology, 2014

View PDFchevron_right

IL (Interleukin)-1α Promotes Nuclear Factor-κB and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas

Naofumi Mukaida

Clinical Cancer Research, 2001

View PDFchevron_right

Pro-inflammatory Genes as Biomarkers and Therapeutic Targets in Oral Squamous Cell Carcinoma

Z. Pavicevic

Journal of Biological Chemistry, 2010

View PDFchevron_right

Enhanced Expression of Transforming Growth Factor Beta One (TGF-Β1) During Progression of Oral Epithelial Dysplasia to Carcinoma

Hamdy Metwaly

Egyptian dental journal, 2016

View PDFchevron_right

Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease

Nicola Cirillo

PloS one, 2017

View PDFchevron_right

Stromal cell-derived factor-1 (SDF-1 /CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF- B/interleukin-6 pathway

Cheng-chi Chang

Carcinogenesis, 2008

View PDFchevron_right

Role of Inflammation in Oral Squamous Cell Carcinoma

Kivanc Bektas-kayhan

InTech eBooks, 2012

View PDFchevron_right

Expression of pro-inflammatory protein, iNOS, VEGF and COX2 in Oral Squamous Cell Carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation

Kittipong Dhanuthai, Kraisorn Sappayatosok, Julien Zwang

2009

View PDFchevron_right

CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis

John R Gordon, PhD, FCAHS

Oncotarget, 2015

View PDFchevron_right

A New Strategy to Find Targets for Anticancer Therapy: Chemokine CXCL14/BRAK Is a Multifunctional Tumor Suppressor for Head and Neck Squamous Cell Carcinoma

Ryu-Ichiro Hata

ISRN otolaryngology, 2012

View PDFchevron_right

Induction of chemokine receptor CXCR4 expression by transforming growth factor-β1 in human basal cell carcinoma cells

Yi-Shuan Sheen

Journal of Dermatological Science, 2013

View PDFchevron_right

Cancer‐associated fibroblast‐derived interleukin‐1β activates protumor C‐C motif chemokine ligand 22 signaling in head and neck cancer

Li-Wha Wu

Cancer Science, 2019

View PDFchevron_right

Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach

Flavia Ribeiro

Anticancer research, 2014

View PDFchevron_right

Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer (original) (raw)

Related papers